Beijing Youth Daily reporter learned from Hubei maternal and child health hospital that on the 18th, the first domestic bivalent HPV vaccine (cervical cancer vaccine) was vaccinated in Hubei maternal and child health hospital. Keke (a pseudonym), a 10-year-old girl from Wuhan, became the first vaccinator in China. Her mother Peng, who was vaccinated with her, was an obstetrician. This means that the domestic HPV vaccine that has attracted widespread attention has finally 'landed', and the HPV vaccine has entered the 'domestic era'. It is understood that compared with the vaccines that have been listed in China, the domestic vaccines have international quality and higher cost performance. The suitable population is 9-45 years old, and only 2 injections are required in the age group of 9-14 years old.
On the afternoon of the 18th, Ms. Peng, 44, brought her 10-year-old daughter cocoa to the adult vaccine clinic of the women's Health Department of Hubei maternal and child health hospital and asked for domestic HPV vaccine. Cocoa became the first woman in China to be vaccinated with domestic bivalent HPV vaccine. Subsequently, Ms. Peng was vaccinated, becoming the second vaccinated woman in the country. Check personal information, pay fees and receive vaccination. The whole process is completed in a few minutes.
Ms. Peng is an obstetrician with rich clinical experience and medical knowledge. "Fortunately, my daughter and I have become the top two vaccinators of domestic cervical cancer vaccine." Ms. Peng said that before deciding to vaccinate herself and her children with domestic cervical cancer vaccine, she carefully studied the differences between bivalent, tetravalent and jiuvalent vaccines, as well as the relevant data of imported and domestic vaccines. She concluded that the protection efficiency of domestic bivalent vaccine against high-risk HPV virus is the same as that of imported vaccine, but the price is at least half cheaper, and there is no need to queue up for vaccination, which saves a lot of things.
Before the domestic cervical cancer vaccine was approved, there were imported bivalent, tetravalent and jiuvalent HPV vaccines, which were applicable to women aged 9-45, 20-45 and 16-26 years respectively. As early as November 2017, the Provincial Maternal and child health hospital successively opened the reservation vaccination of imported bivalent, tetravalent and jiuvalent HPV vaccines. In the past three years, the heat of HPV vaccine reservation has not decreased, and it is very popular. The nine valent vaccine is the most 'popular'.
At present, more than 104 countries and regions in the world have incorporated HPV vaccine into national immunization planning, and the main vaccinated population is 9-14 years old.
Over the years, Chinese people's attention to the R & D and listing of domestic vaccines also includes the expectation of reducing costs. The price of domestic bivalent HPV vaccine is 329 yuan / piece, which is lower than that of similar products. Moreover, people aged 9-14 only need two shots. At present, the domestic bivalent HPV vaccine in Hubei maternal and child health hospital has arrived. However, experts remind that cervical cancer vaccination is not 'once and for all'. Cervical cancer vaccine can not produce 100% protective effect, can not replace routine cervical cancer screening, nor can it replace other measures to prevent HPV infection and sexually transmitted diseases. Therefore, routine cervical cancer screening can not be ignored.